Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KRT78 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | OTOP2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | PIK3R2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | GRHL2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
mRNA | CDH1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
mRNA | HERPUD2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | CTDSPL | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
mRNA | CTB-50L17.10 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | TAX1BP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | CELF1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |